BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18400455)

  • 1. Inflammation and aging: can endocannabinoids help?
    Marchalant Y; Brothers HM; Wenk GL
    Biomed Pharmacother; 2008; 62(4):212-7. PubMed ID: 18400455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the endocannabinoid system in Alzheimer's disease.
    Koppel J; Davies P
    J Alzheimers Dis; 2008 Nov; 15(3):495-504. PubMed ID: 18997302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease.
    Bonnet AE; Marchalant Y
    Aging Dis; 2015 Sep; 6(5):400-5. PubMed ID: 26425394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid System in Neurological Disorders.
    Ranieri R; Laezza C; Bifulco M; Marasco D; Malfitano AM
    Recent Pat CNS Drug Discov; 2016; 10(2):90-112. PubMed ID: 27364363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
    Karl T; Cheng D; Garner B; Arnold JC
    Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease.
    Rapaka D; Bitra VR; Challa SR; Adiukwu PC
    Neuropeptides; 2021 Dec; 90():102196. PubMed ID: 34508923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
    Bisogno T; Di Marzo V
    Curr Pharm Des; 2008; 14(23):2299-3305. PubMed ID: 18781980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system in neurodegenerative disorders.
    Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
    J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids in appetite control and the treatment of obesity.
    Kirkham TC; Tucci SA
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):272-92. PubMed ID: 16787229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.
    Estrada JA; Contreras I
    Curr Neuropharmacol; 2020; 18(8):769-787. PubMed ID: 32065105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
    Karanian DA; Bahr BA
    Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system and Alzheimer's disease.
    Benito C; Núñez E; Pazos MR; Tolón RM; Romero J
    Mol Neurobiol; 2007 Aug; 36(1):75-81. PubMed ID: 17952652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system: an osteopathic perspective.
    McPartland JM
    J Am Osteopath Assoc; 2008 Oct; 108(10):586-600. PubMed ID: 18948642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
    Pagotto U; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacology of the endocannabinoids: far beyond anandamide.
    Pamplona FA; Takahashi RN
    J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system in chronic liver disease.
    Zamora-Valdés D; Ponciano-Rodríguez G; Chávez-Tapia NC; Méndez-Sánchez N
    Ann Hepatol; 2005; 4(4):248-54. PubMed ID: 16432489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.